Hashad Yehia 4

What Happened
Hashad Yehia, EVP of Research & Development and Chief Medical Officer at Bausch & Lomb (BLCO), had 13,664 common shares withheld to satisfy tax withholding obligations upon the vesting of restricted share units. The withholding was recorded at $16.00 per share for a total value of $218,624. This is a routine tax-withholding event (transaction code F), not an open-market sale or purchase.

Key Details

• Transaction date: 2026-05-05; Filing date: 2026-05-07 (appears timely under Form 4 rules).
• Shares withheld/disposed: 13,664 at $16.00 per share; total value $218,624.
• Transaction code: F — payment of exercise price or tax liability (shares withheld for taxes).
• Footnote: F1 — number represents common shares withheld to satisfy tax withholding due upon RSU vesting.
• Shares owned after transaction: Not specified in the provided filing summary.

Context
Tax-withholdings on vested RSUs are routine and do not necessarily indicate insider buying or selling sentiment. Unlike an open-market sale, withheld shares are used solely to cover tax obligations and typically result in no cash proceeds to the insider.